- Report
- June 2026
- 330 Pages
Global
From €4436EUR$4,950USD£3,806GBP
- Report
- January 2026
- 180 Pages
Global
From €5332EUR$5,950USD£4,575GBP
- Report
- February 2026
- 250 Pages
Global
From €4024EUR$4,490USD£3,452GBP
- Report
- August 2026
- 386 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- August 2026
- 372 Pages
Global
From €5243EUR$5,850USD£4,498GBP
- Report
- November 2025
- 140 Pages
Global
From €4347EUR$4,850USD£3,729GBP
- Report
- July 2025
- 136 Pages
Global
From €4167EUR$4,650USD£3,575GBP
- Report
- April 2023
- 113 Pages
Global
From €4257EUR$4,750USD£3,652GBP
- Report
- July 2023
- 164 Pages
Turkey, Middle East, Africa Turkey, Middle East, Africa
From €3092EUR$3,450USD£2,653GBP
- Report
- October 2024
- 84 Pages
Global
From €3500EUR$4,184USD£3,108GBP
- Report
- October 2024
- 86 Pages
Global
From €3500EUR$4,184USD£3,108GBP
- Book
- May 2016
North America

The Platelet Transfusion market is a subset of the Blood Banking industry. Platelet transfusions are a medical procedure used to treat patients with low platelet counts, which can lead to excessive bleeding. Platelets are collected from healthy donors and stored in a blood bank before being transfused into a patient. Platelet transfusions are used to treat a variety of conditions, including cancer, thrombocytopenia, and autoimmune disorders.
The Platelet Transfusion market is highly regulated, with strict guidelines for donor selection, storage, and transfusion. Quality assurance is a key component of the market, as platelet transfusions must be safe and effective for the patient. Additionally, the market is highly competitive, with a variety of companies offering platelet transfusions.
Some companies in the Platelet Transfusion market include American Red Cross, Grifols, CSL Behring, and Octapharma. Show Less Read more